Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
Praxis develops therapies for CNS disorders by leveraging genetic insights into neuronal imbalances, targeting rare to common conditions.
Bactolife is a biotechnology company that develops biological solutions to support gut health.
Sidera Bio harness human genetics, that helps in transformative medicines for patients.
Blue Planet Environmental Solution provides sustainable and socially inclusive end-to-end environmental solutions.
Chromologics develops innovative natural food colorants.
Booster Therapeutics is a biotech company that offers regulation of cellular homeostasis, as well as develops medicines for aging diseases.
Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.
EnergyRe is at the center of the clean energy future.
Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.
MATR Foods is a food-tech startup that provides fungi-based food ingredients.
Cleveland Diagnostics is a diagnostics company developing efficacious, affordable diagnostics tests to improve cancer diagnostics.
LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.
KalVista Pharmaceuticals focuses on developing oral medicines, particularly for managing hereditary angioedema.
Nalu Medical is a medical technology company that offers neurostimulation system designed to treat chronic nerve pain.
Phasecraft develops quantum algorithms and related intellectual property for scientific and industrial applications.
Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.
GlycoEra is a biotechnology research company that produces extracellular protein degraders for the treatment of autoimmune diseases.
Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions.
Glycomine is an early-stage biotech working on replacement therapies for rare diseases.
HepaRegeniX is developing drugs for treating acute and chronic liver diseases.
Sparrow Quantum develope and commercializes photonic quantum chip technology.
Supira Medical is a clinical-stage company that develops catheter-based circulatory support devices for patients with heart conditions.
Tribune Therapeutics specializes in building promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.
Novo Holdings has invested in 216 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Novo Holdings's top investment sectors include Biotechnology, Medical, Health Care, Pharmaceutical, Therapeutics. The firm invests across 30 different industry categories.
Among tracked funding rounds, Praxis Precision Medicines received $575.0M in a Post-IPO Equity round. Novo Holdings's total known invested capital is $18.6B.
Novo Holdings's average investment size is $86.1M across its portfolio of 216 companies.
Recent Novo Holdings portfolio additions include Muna Therapeutics, Praxis Precision Medicines, Bactolife, Sidera Bio, Blue Planet Environmental Solution. These companies were founded in 2020 or later.